Five-year outcomes of stereotactic body radiation therapy (SBRT) for prostate cancer: the largest experience in China.
Xianzhi ZhaoYusheng YeHaiyan YuLingong JiangChao ChengXueling GuoXiaoping JuXiaofei ZhuHuojun ZhangPublished in: Journal of cancer research and clinical oncology (2021)
SBRT is an efficient and safe treatment modality for localized PCa with high 5-year bPFS rates and acceptable toxicities.